Abstract
Heart failure (HF) is the end-stage scenario common to all different types of cardiomyopathies. It is characterized by an imbalance between the oxygen delivered by the cardiac output and the need of peripheral organs and tissues [1]. However, the clinical picture, the time course of its occurrence, and its treatment can vary according to the different underlying diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ponikowski P et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200
Owan TE, Hodge DO, Herges RM et al (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259
Kirklin JK et al (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34(12):1495–1504
Elliott P, Andersson B et al (2008) Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270–276
Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39
Grigioni F et al (2005) Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol 45(2):260–267
Piano MR (2002) Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121:1638–1650
Cerqueira MD et al (1991) Rarity of preclinical alcoholic cardiomyopathy in chronic alcoholics less than 40 years of age. Am J Cardiol 67:183–187
Bovelli D et al (2010) Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol 21:v277–v282
Kindermann I et al (2012) Update on myocarditis. J Am Coll Cardiol 59:779–792
McCarthy RE et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695
Grody WW et al (1990) Infection of the heart by the human immunodeficiency virus. Am J Cardiol 66:203–206
Raidel SM et al (2002) Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 282:H1672–H1678
Kransdorf EP, Zakowski PC, Kobashigawa JA (2014) Chagas isease in solid organ and heart transplantation. Curr Opin Infect Dis 27(5):418–424
Elkayam U et al (2001) Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344:1567–1571
Gujja P et al (2010) Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol 56:1001–1012
Srichai MB et al (2011) Cardiac sarcoidosis. J Am Coll Cardiol 58:438
Elliott P et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J 35:2733–2779
Biagini E et al (2014) Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy. Am J Cardiol 114(5):769–776
Quarta CC et al (2014) Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation 129(18):1840–1849
Potena L et al (2014) Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. J Heart Lung Transplant 33(2):136–138
Reich HJ et al (2015) Combined heart and liver transplantation: the Cedars-Sinai experience. Transplant Proc 47(9):2722–2726
Basso C et al (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373(9671):1289–1300
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Grigioni, F., Potena, L., Marinelli, G., Masetti, M. (2017). Cardiomyopathies and Clinical Features. In: Montalto, A., Loforte, A., Musumeci, F., Krabatsch, T., Slaughter, M. (eds) Mechanical Circulatory Support in End-Stage Heart Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-43383-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-43383-7_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43381-3
Online ISBN: 978-3-319-43383-7
eBook Packages: MedicineMedicine (R0)